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Summary
Current evidence on Acute Kidney Injury and venous congestion
Up to only a decade ago, Acute Kidney Injury (AKI) in critically ill patients seemed to be a 
straightforward and low impact problem, often primarily caused by insufficient perfusion, or low 
cardiac index. In chapter 2 we showed that cardiac index was not associated with AKI, while 
variables of right ventricular function were. This led to the hypothesis that in contrast with cardiac 
afterload venous congestion might be one major contributing factor to AKI in the critically ill.
Designing an observational study to investigate AKI and venous congestion
Before evaluating the additional contribution of venous congestion as risk factor to existing 
known risk factors for the development of AKI, a baseline prognostic model for AKI needs to 
be established. In chapter 3 we identified a set of baseline (easily and immediately available) 
clinical signs which are independently associated with AKI. This retrospective analysis did not 
only identify the variables to be included and collected in the prospective study, but may also 
inform the identification of high-risk patients in settings where more sophisticated techniques 
are unavailable. In chapter 4 we described the protocol of a prospective observational study to 
assess the association between AKI and venous congestion; the Simple Intensive Care Studies-II 
(SICS-II).
Two complex clinical syndromes
At first glance AKI may seem, despite its complex pathophysiology, a rather straight forward 
binary outcome or complication of critical illness. When applying the Kidney Disease Improving 
Global Outcome (KDIGO) definition, different methods may lead to various incidences, which 
was elaborated in chapter 5. No definition exists to describe the concept of venous congestion, 
which is why we measured multiple proxies that could potentially approximate this complex 
state of system failure. In chapter 6, we studied arterial and venous renal Doppler ultrasound, and 
showed that both had limited diagnostic accuracy for AKI. Finally, all assessed signs of venous 
congestion were combined in chapter 7, in which we studied the association between all 
repeated collected signs of venous congestion and AKI. Fluid balance, the presence of peripheral 
edema and reduced right ventricular function were associated with AKI.
Heterogeneity of AKI and associated outcomes
AKI is a complex entity. First, variation according to differences in the applied definition complicates 
its research (chapter 5). Second, the syndrome itself develops due to many potential different 
pathophysiologic pathways, and it is thus plausible that specific pathways are more prominent in
distinct subphenotypes of AKI. In chapter 8, a post-hoc analysis of the FINNAKI study, two different 
subphenotypes of septic AKI were identified which had different characteristics regarding renal 
recovery and 90-day mortality.
Finally, these different causes of heterogeneity likely contribute to varying associations between 
AKI and mortality. In chapter 9 we propose AKI burden, a variable which captures both the 
duration and the severity of AKI, and we show that AKI burden may improve the prediction of 90-
day mortality compared to simplified variables like any AKI, severity of AKI or duration of AKI only.
Summary,
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General discussion
The underlying hypothesis of this thesis was that venous fluid overload could lead to increased 
renal ‘’afterload’’ or increased renal venous pressure, and in that way, contribute to the development 
or aggravate the severity of AKI. During the conduct of this thesis, multiple intervention studies 
have been initiated and conducted which investigate whether restrictive fluid therapy is 
associated with lower AKI occurrence. We attempted to study venous congestion and AKI, and 
their association using diagnostic and prognostic approaches in combined cross sectional and 
cohort study designs. The evaluation of venous congestion and AKI and their association was 
much more complex as anticipated. First, AKI is a very complex syndrome defined by criteria 
which are open to various interpretations. Second, the concept of venous congestion is still 
undefined and cannot be exactly measured or sufficiently estimated, while it is probably best 
defined by venous fluid overload approximated by various surrogate variables, such as elevated 
right atrial pressure or peripheral edema.
Acute Kidney Injury, a seemingly simple syndrome
AKI is a prevalent complication of critical illness, and incidences range from 14% to 75% in cohorts 
depending on selection criteria and application of the criteria used. There is no specific treatment 
other than supportive care once AKI occurs, so the current aim is to prevent the occurrence of AKI. 
Hence, accurate prognostic models are needed to identify the patients at risk for AKI, as described 
throughout this thesis.
Classification of AKI
The Kidney Disease Improving Global Outcomes (KDIGO) criteria are employed to define AKI, but 
can be applied and interpreted in several ways. In randomized clinical trials, patients are selected 
based on the occurrence of AKI, or the outcome of AKI is reported based on these criteria, so it 
is extremely important to have a consensus about how AKI can be unambiguously defined and 
reported. In the Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive 
Care (CLASSIC) trial, which was designed to evaluate whether either restrictive or (more) liberal 
fluid administration is beneficial in patients with septic shock, one of the secondary aims is to 
assess the impact of various fluid strategies on AKI, where this outcome is defined as ”modified 
KDIGO-3”.1 The researchers seem to have chosen this classification of AKI as it is described as a 
serious adverse outcome, indirectly acknowledging that not all types of AKI are equally severe. 
It is likely that urine output data, needed for AKI classification, is collected in different ways in 
such multicentre trials, which may also translate to different AKI incidences and thus different 
associations with outcomes. In various studies therefore the urine output criteria for AKI have 
been set to an average 12-hourly threshold rather than actual hourly assessments.2 For trials 
investigating both AKI and venous congestion, it is important to appreciate AKI heterogeneity 
while also standardizing methods for AKI diagnosis throughout different study sites to improve 
the generalizability of their results.
General discussion
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The complexity of venous congestion
The concept of venous congestion is not new. In patients with heart failure, venous congestion 
has been shown to be associated with unfavourable outcomes.3 In critically ill patients, venous 
congestion has only been investigated by single surrogate measures, such as either fluid overload 
or peripheral edema.4,5 In these studies however, various definitions for venous congestion and 
various definitions for AKI have been used, which complicate comparison of data. The concept of 
venous congestion is not defined at all yet, but several surrogate measures can be used to assess 
its presence. Some surrogate measures may be more general and systemic, like the presence of 
pulmonary edema or fluid balance, while other surrogates may be more specific, such as renal 
ultrasound measures of arterial and venous flow. Based on previous literature we evaluated 
multiple surrogate measures to assess venous congestion in critically ill patients, even though all 
these surrogate measures have their limitations.
For example, the fluid balance reflects the total amount of fluids which has been given to a 
patient minus the total amount of fluids that the patient has lost. A very high positive cumulative 
fluid balance could potentially be associated with venous congestion and it has previously been 
suggested to be associated with increased incidences of AKI.4,6,7 There are, however, several issues 
which complicate accurate registration and interpretation of fluid balance. First, at what point 
in time, should the data collection start? Most registration systems start data registration upon 
ICU admission, while illness frequently begins long before ICU admission and so the patient has 
already been given many fluids or has already lost many fluids before ICU admission or even 
hospital admission. Second, it is a challenging task to exactly track all fluid intake and output, as 
registration and estimation of all details may be too time-consuming for health care personnel, 
especially in regular wards or simply impossible (like insensible losses). Last, if these issues were 
to be taken for granted, the situation in the ICU is both highly complex and highly dynamic so 
that the large amount of registrations make the fluid balance prone for measurement error, and 
therefore, should be interpreted with caution.
Surrogate measurements obtained by ultrasound may be easy to measure but clinical applicability 
can be limited, and in this thesis, only few appeared to be associated with AKI. Even though 
ultrasound is an up and coming technique, which is patient-friendly and accessible for physicians, 
some pitfalls must be acknowledged. Most importantly, ultrasound is operator dependent which 
bears some consequences; first, adequate training for appropriate techniques and measurements 
is required, second, experts should independently validate images and measures, and third; as 
interrater variability by definition exists, only crude measures can reliably be used, reassessed 
and change evaluated over time. The latter, however, also poses a beneficial characteristic: as 
measures are best-used crude, they can be obtained rather quickly and with limited training.
Acute Kidney Injury and Venous congestion
Early 2019, Mullens et al. published a position statement in the European Journal of Heart Failure 
considering the use of diuretics in patients with heart failure and congestion.8 Although this was 
a position statement specifically focused on patients with heart failure, it is mentioned that no 
Chapter 10
547452-L-bw-Wiersema
Processed on: 25-8-2020 PDF page: 183
183  
study has prospectively evaluated multiple surrogate measures including clinical, ultrasound 
and biomarker variables. Two examples that have integrated surrogate (ultrasound) measures to 
describe venous congestion, have done so in relatively small patient samples and predominantly 
during the perioperative period.9,10 Recently, a book was published in which a chapter describes 
the assessment of venous congestion using ultrasound with a proposed VExUS score.11 The 
VExUS score stratifies the severity of venous congestion into several grades based on multi organ 
ultrasound assessment.11 In a prospective study including 145 patients after cardiac surgery they 
found that severe congestion was associated with AKI.12 Even though such a score might seem 
promising and useful for clinical practice, it still necessitates a solid evidence base by validation in 
externally replicated cohort studies.
This thesis showed that signs of venous congestion may increase the risk of AKI. Liberal fluid 
therapy, which may result in venous congestion, has been associated with worse outcomes 
compared to conservative fluid therapy.13 One of the biggest research questions in current 
critical care practice is to outline which patients benefit from timely administered fluid therapy 
and which patient suffer harm from fluid. The findings in this thesis suggest that fluid therapy 
might have adverse effects in patients at risk of AKI if signs of venous congestion are present. 
The observational nature of the data presented in this thesis provides hypotheses on venous 
congestion, but randomised trials need to provide causal evidence for recommendations and 
guidelines for use of fluid therapy, or alternatively fluid removal, in clinical practice.
General discussion
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Future perspectives
Substantial heterogeneity remains among critically ill patients and (the pathophysiology of ) their 
AKI episodes. Before new studies are designed to investigate AKI or various fluid strategies, it is 
important to reach a consensus on the method of definition and stratification of AKI.14
For venous congestion a definition is needed as well. This definition should include crude 
estimates of multiple surrogate measures or perhaps normal values for a given population may 
provide some sort of reference values for the degree of venous congestion. Future studies could 
further delineate which surrogate measures are most useful to consider when the diagnosis of 
venous congestion is at question and could equally serve as triggers or targets for interventions.
Two patients suffering from a similar clinical syndrome can be immensely different and may have 
very divergent outcomes. Subphenotypes of complex clinical syndromes exist, and likely these 
require different treatment. Investigating subphenotypes of clinical syndromes may decrease 
heterogeneity in research cohorts and could stimulate future research towards precision 
medicine and personalized care for the critically ill patient. For example, a better outcome may 
be achieved if triggers of venous congestion were to be combined with baseline, clinical, and 
biomarker data for a more detailed patient characteristic for targeting interventions-tailored 
estimation of treatment requirements. However, the question whether these associations 
are based on correlation or causality remains.15 Centres could collaborate in this matter and 
collect a sufficient amount of data following a standardized protocol structurally. A resulting 
multinational cohort could facilitate the assessment of subphenotypes for multiple complex 
and heterogeneous syndromes. Moreover, this provides the opportunity to create individual, 
preferentially multivariable, intervention triggers, adapted to the individual clinical situation, 
instead of treating patients based on population-based normal values.
The overarching goal is to develop easily implementable and interactive prognostic models for 
syndromes such as AKI upon ICU admission, to be able to start personalized prevention and 
treatment of underlying illness. Various recent initiatives are working towards such solutions, such 
as a nomogram to estimate the risk of septic AKI risk, or a tool to predict Major Adverse Kidney 
Events (MAKE).16,17
Future trials could assess whether use of vasopressors rather than fluid therapy decreases AKI 
incidence, or if certain interventions such as active fluid removal could prevent further risk of 
adverse outcomes in patients with severe venous congestion and AKI.
Life after AKI and critical illness
Finally, while this thesis focused mainly on the interaction between venous congestion, AKI, and 
mortality, the most relevant question for patients concerns life after their ICU stay. Fortunately, 
many patients do survive ICU but we do not yet comprehend the impact of AKI on long term 
patient quality of life. Future studies investigating AKI and subsequent treatment should thus 
Future perspectives
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also focus on how these affect the development of comorbidities and consequently, quality of 
life. The use of collaborative research infrastructures and the identification of subphenotypes of 
complex syndromes should be combined with a team that focuses on gathering outcome data 
that are most relevant to patients. After all, surviving ICU admission with high AKI burden and a 
long recovery is worth nothing if the joys of life can no longer be enjoyed.
Chapter 10
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